南美洲和中美洲血浆衍生物市场预测至 2028 年 - COVID-19 影响和按类型（白蛋白、因子 VIII、因子 IX、免疫球蛋白、超免疫球蛋白等）、应用（血友病、低丙种球蛋白血症、免疫缺陷病、血管性血友病）的区域分析疾病等）和最终用户（医院、诊所等）
No. of Pages: 137 | Report Code: BMIRE00028490 | Category: Life Sciences
No. of Pages: 137 | Report Code: BMIRE00028490 | Category: Life Sciences
免疫球蛋白G (IgG) 疗法广泛用于治疗由遗传引起的原发性免疫缺陷。由于人们对 IgG 疗法的认识不断提高，过去几年对 IgG 的需求一直在稳步增长。这一增长也归因于其新确定的适应症的新疗法。根据网络荟萃分析 (NMA) 进行的对照试验，IgG 疗法已被批准用于治疗格林-巴利综合征；综合征（GBS）、慢性炎症性脱髓鞘性多发性神经病（CIDP）、多灶性运动神经病（MMN）和皮肌炎。免疫球蛋白 G (IgG) 疗法对于治疗重症肌无力加重和僵人综合症也有效。此外，它对癫痫、神经脊髓炎和自身免疫性脑炎等自身免疫性疾病也具有令人信服的功效。
很大一部分 IgG 用于免疫学以外的专业，例如肿瘤学、神经病学、血液学和风湿病学。与所有专业相比，神经病学是全球市场上增长最快的专业。免疫球蛋白G市场的增长归因于其被批准用于治疗慢性炎症性脱髓鞘性多发性神经病（CIDP），随后又被批准用于治疗淋巴瘤、骨髓瘤和白血病引起的继发性免疫缺陷以及某些免疫抑制疗法尤其是B细胞靶向治疗。因此，未来几年，IgG 在标签内和标签外处方的多种治疗中的广泛使用将继续扩大并推动全球市场的 IgG 需求。
南部和中部地区中美洲血浆衍生品市场已细分为巴西、阿根廷和南美其他地区。中美洲。该地区血友病、血管性血友病和其他出血性疾病的患病率很高，因此越来越多地采用血浆衍生物产品进行治疗。例如，根据世界血友病联合会 (WFH) 2021 年年度全球调查，巴西和阿根廷的活动性血友病、冯维勒布兰德病和其他出血性疾病病例数量明显较多。 2021 年，巴西有 13,337 人患有血友病，10,231 人患有血管性血友病，3,959 人患有其他出血性疾病。与此同时，阿根廷有 2,843 名血友病患者、399 名血管性血友病患者和 11 名其他出血性疾病患者。
此外，根据 CDC（美国疾病预防控制中心）的数据，卫生与公众服务部），巴西等国家建议对疫苗成分过敏或年龄小于 6 个月的旅行者应接受单剂免疫球蛋白，这可提供长达 2 个月的有效保护，具体取决于根据给定的剂量。此外，全球多家血浆衍生品制造商正在将业务扩展到南美和南美。中美洲，促进市场增长。例如，2019 年 11 月，Grifols 宣布位于巴西坎波拉戈的新采血系统工厂开始生产。该生产线正在满足该地区当地客户的订单。年产能超过1000万个采血袋，超过5500平方米的厂房预计将逐步增加产量，服务更广泛的拉美地区。
南美洲和南美洲中美洲血浆衍生物市场按类型、应用、最终用户和国家细分。
南美洲和南美洲中美洲血浆衍生物市场按类型分为白蛋白、因子VIII、因子IX、免疫球蛋白、超免疫球蛋白等。免疫球蛋白细分市场到 2022 年将占据更大的市场份额。
根据应用情况，南美市场中美洲血浆衍生物市场分为血友病、低丙种球蛋白血症、免疫缺陷病、冯维勒布兰德病等应用。到 2022 年，免疫缺陷疾病应用领域将占据最大的市场份额。
血浆衍生物市场按最终用户划分，分为医院、诊断实验室、诊所和其他最终用户。到 2022 年，医院细分市场将占据最大的市场份额。
按国家/地区划分，南部和南部地区中美洲血浆衍生品市场分为巴西、阿根廷和南美洲其他地区。中美洲。沙特阿拉伯将在 2022 年占据市场主导地位。
Grifols SA；奥克塔制药公司；莫诺宾德公司； CSL 贝林有限责任公司； LFB SA; Kedrion SpA；和武田制药有限公司是在南部和南部地区运营的领先公司。中美洲血浆衍生品市场。
Strategic insights for South & Central America Blood Plasma Derivatives involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,864.04 Million |
| Market Size by 2028 | US$ 3,067.15 Million |
| Global CAGR (2022 - 2028) | 8.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South & Central America Blood Plasma Derivatives refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Blood Plasma Derivatives Market is valued at US$ 1,864.04 Million in 2022, it is projected to reach US$ 3,067.15 Million by 2028.
As per our report South & Central America Blood Plasma Derivatives Market, the market size is valued at US$ 1,864.04 Million in 2022, projecting it to reach US$ 3,067.15 Million by 2028. This translates to a CAGR of approximately 8.7% during the forecast period.
The South & Central America Blood Plasma Derivatives Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Blood Plasma Derivatives Market report:
The South & Central America Blood Plasma Derivatives Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Blood Plasma Derivatives Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Blood Plasma Derivatives Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Blood Plasma Derivatives Market
